Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Public Health Genomics and Precision Health Knowledge Base (v5.9)

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov.

HuGE Navigator|HuGE Literature Finder|PHGKB

HuGE Literature Finder

Records 1-6

Query Trace: Weight Loss and EGFR[orginal query]

Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations? Future oncology (London, England) 2018 Mar . Rossi Sabrina, Di Noia Vincenzo, Tonetti Laura, Strippoli Antonia, Basso Michele, Schinzari Giovanni, Cassano Alessandra, Leone Antonio, Barone Carlo, D'Argento Etto Similar articles in PubMed
Impact of Weight Loss at Presentation on Survival in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) Sensitive Mutant Advanced Non-small Cell Lung Cancer (NSCLC) Treated with First-line EGFR-TKI. Journal of Cancer 2018 9 (3): 528-534. Lin Liping, Zhao Juanjuan, Hu Jiazhu, Huang Fuxi, Han Jianjun, He Yan, Cao Xiaolo Similar articles in PubMed
Risk factors and prognosis value of venous thromboembolism in patients with advanced non-small cell lung cancer: a case-control study. Journal of thoracic disease 2017 Dec 9 (12): 5068-5074. Shen Qian, Dong Xiaoqi, Tang Xiaoping, Zhou Jianyi Similar articles in PubMed
AC0010, an irreversible EGFR inhibitor selectively targeting mutated EGFR and overcoming T790M-induced resistance in animal models and lung cancer patients. Molecular cancer therapeutics 2016 Aug . Xu Xiao, Mao Long, Xu Wanhong, Tang Wei, Zhang Xiaoying, Xi Biao, Xu Rongda, Fang Xin, Liu Jia, Fang Ce, Zhao Li, Wang Xiaobo, Jiang Ji, Hu Pei, Zhao Hongyun, Zhang Similar articles in PubMed
Predictive and prognostic factors in second- and third-line erlotinib treatment in NSCLC patients with known status of the EGFR gene. Oncology reports 2013 Sep 30 (3): 1463-72. Krawczyk Pawe?, Kowalski Dariusz M, Krawczyk Kamila Wojas, Szczyrek Micha?, Mlak Rados?aw, Rolski Andrzej, Szudy Aneta, Kieszko Robert, Winiarczyk Kinga, Milanowski Janusz, Krzakowski Maci Similar articles in PubMed
Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Sep 5 (9): 1382-90. Ready Neal, Jänne Pasi A, Bogart Jeffrey, Dipetrillo Thomas, Garst Jennifer, Graziano Stephen, Gu Lin, Wang Xiaofei, Green Mark R, Vokes Everett E, Similar articles in PubMed

File Formats Help:

How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?

Page last reviewed:Jul 30, 2019
Page last updated:Aug 22, 2019
Content source:

TOP